Eagle's Eye View: Your Weekly CV Update From ACC.org (Week of January 13)

This week's View goes over key points to remember from a state-of-the-art review on peripartum cardiomyopathy, updates from EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients), and key points to remember from the 2019 European Society of Cardiology and European Association for the Study of Diabetes guidelines on diabetes, pre-diabetes, and cardiovascular diseases.

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Anticoagulation Management, Cardiac Surgery, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and Imaging, Echocardiography/Ultrasound, Diet, Exercise, Hypertension

Keywords: EaglesEyeView, Angiotensin-Converting Enzyme Inhibitors, Anticoagulants, Aspirin, Blood Pressure, Cardiomyopathies, Cardiovascular Diseases, Coronary Artery Bypass, Diabetes Mellitus, Type 2, Diet, Echocardiography, Electrocardiography, Exercise, Glucose, Glucose Intolerance, Heart Failure, Hemoglobin A, Glycosylated, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperglycemia, Hypertension, Hypoglycemic Agents, Insulin, Intrauterine Devices, Kidney Diseases, Lactation, Lipids, Maternal Age, Metabolic Syndrome X, Metformin, Myocardial Infarction, Myocardial Ischemia, Natriuretic Peptide, Brain, Obesity, Peripartum Period, Postpartum Period, Pre-Eclampsia, Prediabetic State, Pregnancy, Prenatal Care, Primary Prevention, Secondary Prevention, Risk Factors, Shock, Shock, Cardiogenic, Sulfonylurea Compounds, Thromboembolism, Vascular Diseases, Ventricular Dysfunction, Left

< Back to Listings